Nocuolin A

Nocuolin A is a secondary metabolite derived from the cyanobacterium Nostoc sp., Nodularia sp., and Anabaena sp.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Nocuolin A is a secondary metabolite derived from the cyanobacterium Nostoc sp., Nodularia sp., and Anabaena sp. This secondary metabolite is produced by enzymes of the noc biosynthetic gene group. Also, exhibits anticancer activity that may alter mitochondrial oxidative phosphorylation, thereby inducing antiproliferative effects and apoptosis.

Its structure contains a 3-hydroxypropanoyl group, two alkyl chains, and a 1,2,3-oxadiazine core In 2017, Nocuolin A was isolated from the cyanobacterium strains Nostoc sp. CCAP 1453/38. Nocuolin A was purified using hydrophobic and high-performance countercurrent chromatography (HPCC) and semipreparative HPLC.

Nocuolin A is notable for its antiproliferative, antifouling, anti-amoebic, antiparasitic, and anthelmintic activity. Its antiproliferative activity against tumor cells has an IC 50 between 0.72 and 4.5 µM. Its antifouling activity inhibits marine organisms such as Mytilus galloprovincialis, preventing them from adhering to surfaces.

It can also cause cell death in diatoms such as Navicula sp. The anti-amoebic activity of Nocuolin A induces encystment in Acanthamoeba castellanii (IC50: ~1.7 µM) and Dictyostelium discoideum (IC50: ~0.1 µM). Nocuolin A is effective against protozoa such as Trypanosoma brucei (IC50 = 3.99 µM) and Leishmania infantum (IC50 = 0.21 µM). Finally, its anthelmintic activity results in an inhibition of nematode development.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1368353193 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

2 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.